CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 528 enrolled
Drug / intervention
Aspirin 100mg +1 moredrug
Likely dose
Aspirin 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05257824
NCT05257824Phase 4Completed
CompareCT.gov

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling of Unruptured Intracranial Aneurysms: A Prospective Randomized Multicenter Trial

Seoul National University Bundang Hospital·interventional·Posted Feb 25, 2022·Updated Dec 19, 2025

In Brief

A Phase 4 clinical trial evaluating Aspirin 100mg and Clopidogrel 75mg for Aneurysm Cerebral and Endovascular Procedures. Completed, enrolled 528 participants across 8 sites.

Detailed Summary

Comparison of duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAneurysm Cerebral, Endovascular Procedures
CountriesSouth Korea
CollaboratorsPusan National University Yangsan Hospital, Keimyung University Dongsan Medical Center, Uijeongbu St. Mary's Hospital, Chungnam National University Sejong Hospital, Soonchunhyang University Hospital, Asan Medical Center, Gangnam Severance Hospital, Yonsei University College of Medicine

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedFeb 25, 2022
Enrollment StartJun 23, 2022
Primary CompletionDec 2, 2025
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 4.4 years ago

Interventions

Aspirin 100mgdrug

1. short-term dual antiplatelet: dual antiplatelet agents for 6 months 2. long-term dual antiplatelet: dual antiplatelet agents for 12 months

Clopidogrel 75mgdrug

1. short-term dual antiplatelet: dual antiplatelet agents for 6 months 2. long-term dual antiplatelet: dual antiplatelet agents for 12 months